Combination of Synthetic Long Peptides and XCL1 Fusion Proteins Results in Superior Tumor Control

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.00294
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA


Related search